These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15905721)

  • 21. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging.
    Doré-Savard L; Barrière DA; Midavaine É; Bélanger D; Beaudet N; Tremblay L; Beaudoin JF; Turcotte EE; Lecomte R; Lepage M; Sarret P
    J Nucl Med; 2013 Jun; 54(6):944-52. PubMed ID: 23596003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
    Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure.
    Marzola P; Farace P; Calderan L; Crescimanno C; Lunati E; Nicolato E; Benati D; Degrassi A; Terron A; Klapwijk J; Pesenti E; Sbarbati A; Osculati F
    Int J Cancer; 2003 Apr; 104(4):462-8. PubMed ID: 12584744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
    Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
    J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
    Brasch RC; Daldrup H; Shames D; Wendland M; Okuhata Y; Rosenau W
    Acad Radiol; 1998 Apr; 5 Suppl 1():S2-5. PubMed ID: 9561030
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Washout of small molecular contrast agent in carcinoma-derived experimental tumors.
    Galiè M; Farace P; Merigo F; Fiorini S; Tambalo S; Nicolato E; Sbarbati A; Marzola P
    Microvasc Res; 2009 Dec; 78(3):370-8. PubMed ID: 19804787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood-brain barrier opening and concurrent MR and ultrasound imaging.
    Liao AH; Liu HL; Su CH; Hua MY; Yang HW; Weng YT; Hsu PH; Huang SM; Wu SY; Wang HE; Yen TC; Li PC
    Phys Med Biol; 2012 May; 57(9):2787-802. PubMed ID: 22510713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.
    Saeed M; Lund G; Wendland MF; Bremerich J; Weinmann H; Higgins CB
    Circulation; 2001 Feb; 103(6):871-6. PubMed ID: 11171797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can whole-tumor apparent diffusion coefficient histogram analysis be helpful to evaluate breast phyllode tumor grades?
    Guo Y; Tang WJ; Kong QC; Liang YY; Han XR; Zheng BJ; Sun L; Wei XH; Jin Z; Liu CL
    Eur J Radiol; 2019 May; 114():25-31. PubMed ID: 31005172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.
    Jackson EF; Esparza-Coss E; Wen X; Ng CS; Daniel SL; Price RE; Rivera B; Charnsangavej C; Gelovani JG; Li C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):830-8. PubMed ID: 17379450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis.
    McPhail LD; Robinson SP
    Radiology; 2010 Jan; 254(1):110-8. PubMed ID: 20032145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the maturity and functionality of tumor vasculature by MRI: correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors.
    Baudelet C; Cron GO; Gallez B
    Magn Reson Med; 2006 Nov; 56(5):1041-9. PubMed ID: 16986109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.